Click here to register. 

For assistance completing the online registration process, call 800.422.3106. All attendees must register and pay applicable fees. Walk-in registrations are accepted only if space permits. Pre-registration is strongly recommended.
 

12:30 pm

Registration

1 pm

The New Requirements of Participation: What it Means for Medical Directors, Pharmacist and Other Practitioners

David R. Gifford, MD, MPH
Senior Vice President of Quality and Regulatory Affairs, American Health Care Association

In October 2016 CMS released the most comprehensive overhaul of the nursing facility Requirements of Participation since the implementation of the OBRA rules in 1987.  The new rules focus heavily on person-centered care approaches, the reduction of unnecessary drugs and the reduction of preventable hospitalizations.  The new requirements include a comprehensive facility assessment, much increased infection control requirements which include a formal antibiotic stewardship program, and the implementation of a formal QAPI process that includes the entire disciplinary team.  This session will help participants understand the scope and detail of the requirements and how the participants will need to engage in their provider roles with nursing facilities as implementation of the rules advances through Phases I, II and III.

• Understand the changes in the federal rules which impact medical directors, consultant pharmacists, and other medical practitioners providing care in skilled nursing and nursing facilities.
• Understand the role of the medical director, consultant pharmacist and resident specific medical providers in the development and implementation of the person-centered care plan.
• Understand the role of the medical director and the consultant pharmacist in the implementation of QAPI in nursing facilities.
• Understand the role of the medical director and consultant pharmacist in the expanded infection control program to be required in all facilities.

• Paul Mulhausen MD, MHS
  Chief Medical Officer, Telligen
• Samuel E. Stanton, MD
  Practicing Family Practitioner, Hampton, IA
• Cindy Baddeloo, PhD, MPA, RN
  Senior Vice President and Chief Operating Officer, Iowa Health Care Association
• Mary Jane Carothers, RN, BA, LNHA, ALMC
  Vice President of Quality Improvement and Clinical Services, Iowa Health Care Association

Decisions made by the Iowa 2017 General Assembly and U.S. Congress have a direct impact on day-to-day operations in both your practice and patient care. Our panel members will share state and federal updates and insights on issues impacting PA/LTC practices in Iowa’s nursing and rehab centers. Attendees will also learn about resources the QIO/QIN and AMDA/PALTC have developed to help practitioners successfully adapt to regulatory changes and practices to be successful in the changing healthcare delivery and payment reform landscape.

• Describe approaches for collaboration with your QIOs/QINs to be successful in the changing healthcare delivery and payment reform landscape.
• Identify the impact of the recent state and proposed federal legislation on nursing and rehab centers and other long term services and supports.
• Gain an understanding of Iowa’s performance in quality metrics and benchmarking, as well as, upcoming changes in metrics with value based purchasing.
• Identify the resources available through the Society for Post-Acute and Long-Term Care Medicine.

7:30 am

Breakfast and Networking

8:30 am

Medication-Related Changes and Antimicrobial Stewardship Guidance in MegaRules

Allen Bell, RPh, CGP, FASCP
Director of Clinical Services, Omnicare

Antibiotic stewardship will be a new concept to licensed nurses who have been working exclusively in long term care.  Nursing facility staff members will be looking to medical providers, medical directors and consultant pharmacists to provide information and guidance to draft programs and implement procedures to ensure that antibiotics and other drugs are used effectively and not unnecessarily among the elderly population they serve.  This session will help prepare participants to help nursing facilities implement programs that effectively reduce the use of unnecessary drugs.

• Understand the new federal regulations relating to the use of antibiotics and other potentially unnecessary drugs.
• Have increased role competency while serving as a medical director, consultant pharmacist or other medical providers in relation to the new rules.
• Have increased knowledge of methods for implementing an effective antibiotic stewardship program.
• Have increased knowledge of best practices for identifying and eliminating unnecessary drugs in nursing home populations.

10:15 am

Opioid Use in Long Term Care

• Jeff Reist, PharmD
  Clinical Associate Professor and Director of the Pharmacy Practice Laboratory, University of Iowa College of Pharmacy
• Katy Brown, PharmD
  Clinical Pharmacy Specialist and the Medication Safety Task Coordinator, Telligen Quality Innovation Network-Quality Improvement Organization

This presentation will cover the use of opioids in the treatment of persistent non-cancer pain in the older adult with emphasis on consideration for residents of nursing facilities.  The evidence of the use of opioids will be examined as well as strategies to enhance patient safety when opioid therapy is indicated or required.

• Explain the evidence for the use of opioids in the treatment of persistent pain in older adults
• List specific risks of chronic opioid therapy in older adults
• Calculate a patient-specific risk score for the use of opioid therapy
• Manage opioid therapy in an older adult residing in a long-term care facility in adherence with federal nursing facility regulations and standards of care.

11:45 am

Lunch

12:15 pm

Early Detection and Treatment of Sepsis

• Christopher Hill, DO
  Board Certified Emergency Physician, Allen Hospital, Waterloo, IA
• Geoffrey C. Wall, PhD
  Professor, Department of Clinical Sciences, College of Pharmacy, Drake University
  Director, Drake Drug Information Center

Sepsis in the leading cause of infectious disease mortality in the U.S.  The incidence and mortality of sepsis increases as patients age resulting in long term care residents being at particular risk of developing this condition.  Early recognition and treatment of sepsis can significantly improve outcomes.  This session will review the new screening criteria for sepsis, the 2017 Surviving Sepsis Guidelines and suggest simple, but effective, interventions for screening and the treatment in the long term care setting.

• Describe the qSOFA screening system for sepsis and apply it to long term care patients
• Discuss and implement the new Surviving Sepsis Guidelines
• Assess strategies for fluid resuscitation in early sepsis
• Select appropriate antimicrobials for long term care patients with early sepsis

1:45 pm

Adjourn